View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
November 9, 2016

Biotronik launches Inventra ICD System for patients with higher defibrillation thresholds

German medical technology company Biotronik has launched its Inventra HF-T implantable cardioverter defibrillator (ICD) in the US.

German medical technology company Biotronik has launched its Inventra HF-T implantable cardioverter defibrillator (ICD) in the US.

The device has been designed as a cardiac resynchronisation therapy defibrillator (CRT-D) to deliver ultra-high-energy measuring 42 joules (J) on the first shock to heart failure patients.

An ICD is considered necessary for patients suffering from tachycardia (fast arrhythmias) which converts dangerous arrhythmias to a normal heart rhythm by triggering shocks to the heart.

Jersey Shore University Medical Center electrophysiologist Dr Mark Mascarenhas said: "For an increasing number of patients specifically those with larger cardiac anatomy and lower ejection fraction a shock that is higher than the standard 36-37 J may be needed to convert irregular arrhythmia.

"The sooner an effective shock can be delivered, the likelihood of survival increases for these patients.

"With the availability of Inventra HF-T, more heart failure patients will be able to receive 42J energy delivered upon the first shock and, hence, receive life-saving therapy."

“For such patients, a CRT-D that delivers ultra-high energy on the first shock has a higher chance of converting the irregular arrhythmia.

"With the availability of Inventra HF-T, more heart failure patients will be able to receive 42J energy delivered upon the first shock and, hence, receive life-saving therapy."

The new device is part of the Inventra 7 CRT-D series featuring Biotronik Home Monitoring, ProMRI, CLS, 45 J ultra-high energy and quadripolar LV pacing enabling multiple left-ventricular pacing and sensing configurations for CRT management, thereby offering a powerful therapy for patients at risk of high defibrillation thresholds (DFTs).


Image: Biotronik’s Inventra HF-T CRT device. Photo: courtesy of Biotronik.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU